| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/02/2009 | DE102007030370A1 Acetic acid-solvate of risedronate, useful e.g. to treat or prevent bone resorption disorder, tumors or a disturbed calcium- or phosphate-metabolism |
| 01/01/2009 | US20090005442 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/01/2009 | US20090005437 Alpha-Ketoglutarates and Their Use as Therapeutic Agents |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation |
| 01/01/2009 | US20090005401 Novel Compounds |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005347 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 01/01/2009 | US20090005344 Blocking inflammatory cytokines; tumor necrosis factor; phosphodieaterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders; chronic obstructive pulmonary disorders |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005298 Bone Sialoprotein Collagen-Binding Peptides |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004206 Polynucleotides and Polypeptide Sequences Involved in the Process of Bone Remodeling |
| 01/01/2009 | US20090004196 Method of inhibiting osteoclast activity |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004189 Biological markers predictive of rheumatoid arthritis response to b-cell antagonists |
| 01/01/2009 | US20090004184 Polynucleotides and polypeptides associated with the development of rheumatoid arthritis |
| 01/01/2009 | US20090004174 Fusion Proteins |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004151 Method of Three-Dimesionally Culturing Chondrocytes |
| 01/01/2009 | US20090004136 administering to a cancer patients, heterocyclic trialkyl ammonium-compounds such as [3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethylammonium chloride, to normalize blood cell and platelet counts and to reduce side effects of radiotherapy and chemotherapy |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001551A1 Regulator of activity of bone-forming protein |
| 12/31/2008 | WO2009001214A2 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists |
| 12/31/2008 | WO2009001129A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
| 12/31/2008 | WO2009000877A1 Cysteine protease inhibitors |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2008138131B1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 12/31/2008 | WO2008138131A4 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 12/31/2008 | EP2009025A1 Method of inhibiting osteoclast activity |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2007811A2 Targeted binding agents directed to upar and uses thereof |
| 12/31/2008 | EP2007716A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists |
| 12/31/2008 | EP2007394A1 Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses |
| 12/31/2008 | EP2007370A1 Novel composition for tumor growth control |
| 12/31/2008 | EP1869165A4 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 12/31/2008 | EP1824882A4 Osteoprotegerin variant proteins |
| 12/31/2008 | EP1694335A4 Osteoclastogenesis inhibitors and uses thereof |
| 12/31/2008 | EP1507775B1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 12/31/2008 | EP1465610B1 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation |
| 12/31/2008 | EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 12/31/2008 | EP1412503B1 A fusion protein |
| 12/31/2008 | EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 12/31/2008 | EP1406867B1 Thiolalkyl benzoic acid derivatives |
| 12/31/2008 | EP1364957B1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 12/31/2008 | EP1309587B1 Cinnoline compounds |
| 12/31/2008 | EP1283735B1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/31/2008 | EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis |
| 12/31/2008 | EP1113810B1 Methods of treating multiple myeloma and myeloma-induced bone resorption using antagonists of integrin / receptor binding |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/31/2008 | CN101332296A Dendritic cell vaccine for promoting spinal cord injury function recovery |
| 12/31/2008 | CN101332292A Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
| 12/31/2008 | CN101332291A Medicine for treating intractable rheumatoid arthritis |
| 12/31/2008 | CN101332288A Traditional Chinese medicine knee-cap and making method thereof |
| 12/31/2008 | CN101332262A Medicine sticking for treating lumbar intervertebral disc |
| 12/31/2008 | CN101332223A Medicine for treating bone injuries and its preparation method |
| 12/31/2008 | CN101332166A Hemorrhoid cleaning moisture paper tissue and manufacture method thereof |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 12/31/2008 | CN100446782C Traditional Chinese medicine gels for treating acute gout arthritis |
| 12/31/2008 | CN100446757C Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 12/31/2008 | CN100446701C Cervical vertebra protecting pillow |
| 12/31/2008 | CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | CA2690344A1 Cysteine protease inhibitors |
| 12/31/2008 | CA2689945A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/30/2008 | US7470704 Benzonaphthyridines |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres |
| 12/30/2008 | US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis |
| 12/30/2008 | US7470681 Pyrimidine compounds |
| 12/30/2008 | US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents |
| 12/30/2008 | CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2368767C Protease resistant flint analogs |
| 12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/25/2008 | US20080319071 Novel Nutraceutical and Pharmaceutical Compositions and Use Thereof for the Treatment, Co-Treatment or Prevention of Inflammatory Disorders |
| 12/25/2008 | US20080319044 Compounds and Methods of Use Thereof |
| 12/25/2008 | US20080319026 Substituted n-aryl pyridinones |
| 12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
| 12/25/2008 | US20080318987 Methods for modulating bone formation and mineralization |
| 12/25/2008 | US20080318960 PAR2-modulating compounds and their use |
| 12/25/2008 | US20080318954 Compounds |
| 12/25/2008 | US20080318945 Novel Compounds |
| 12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 12/25/2008 | US20080318872 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/25/2008 | US20080318860 High Activity Growth Factor Mutants |
| 12/25/2008 | US20080318856 administering a monomer protein comprising an amino acid sequence belonging to the TGF- beta super family, wherein alanine at position 83 is replaced with a serine, threonine or valine; protein induces differentiation of osteoblasts measured by promoting alkaline phosphatase activity to a patient |
| 12/25/2008 | US20080318838 Peptides |
| 12/25/2008 | US20080317868 Composition for improving membrane composition and functioning cells |
| 12/25/2008 | US20080317849 Method for Improving the Medical Treatment of Pain |
| 12/25/2008 | US20080317842 Fast Wet-Massing Method for the Preparation of Calcium-Containing Compositions |
| 12/25/2008 | US20080317826 Porous keratin constructs, wound healing assemblies and methods using the same |
| 12/25/2008 | US20080317807 Strontium fortified calcium nano-and microparticle compositions and methods of making and using thereof |